Molecular Imaging: Page 19

Curasight joins forces with Curium

By AuntMinnieEurope.com staff writers

Danish theranostics technology developer Curasight has formed a global partnership with nuclear medicine firm Curium to support the development of its uTrace radiopharmaceutical for use in prostate cancer.

May 2, 2023

Combining PET/CT and MRI can predict outcome in cervical cancer

By Philip Ward

The combination of PET/CT and MRI response assessment after chemoradiotherapy in cases of locally advanced cervical carcinoma (LACC) is a more accurate predictor of patient outcome than either modality alone, U.K. researchers have reported in a new award-winning study.

May 2, 2023

GE HealthCare posts revenue gains in Q1

By AuntMinnieEurope.com staff writers

GE HealthCare produced double-digit percentage organic growth in first-quarter revenue, as well as adjusted earnings before interest and taxes and earnings per share.

April 27, 2023

Telix acquires Vienna's Dedicaid for over 1 million euros

By AuntMinnieEurope.com staff writers

Telix Pharmaceuticals has acquired Vienna, Austria-based Dedicaid, a spin-off of the Medical University Vienna, for $1.2 million (1.1 million euros).

April 27, 2023

Emerging PET tracer for prostate cancer displays promise

By Will Morton

PET/CT imaging with F-18 PSMA-1007 detects significantly more prostate cancer than imaging using the standard F-18 fluorocholine radiotracer, according to clinical trial results published in the April issue of the Journal of Nuclear Medicine.

April 27, 2023

On your bike: A day in the life of Paul McCoubrie

By Dr. Paul McCoubrie

Ranting about the iniquities of clinicians and laboriously detailing your burnout helps no one, writes Dr. Paul McCoubrie in a new column. He's a passionate believer in decent coffee, black pudding for breakfast, cycling to work, and being a good colleague.

April 24, 2023

German team elaborates on how to reduce PET/MRI scan times

By Will Morton

PET/MRI breast cancer imaging time can be cut in half without losing key diagnostic information, and this could increase the use of the modality for this indication and streamline patient throughput, investigators from the University of Dusseldorf have found.

April 20, 2023

PET/CT proves superior in detecting invasive breast cancer

By Will Morton

PET/CT imaging surpasses bone scintigraphy for detecting bone metastases in women with invasive breast cancer and should be the technique of choice to stage these patients, according to a team of investigators from Portugal.

April 16, 2023

Danish team uses PET/CT to predict outcome in metastatic breast cancer

By Will Morton

F-18 FDG-PET/CT imaging appears to be a better predictor of survival than contrast-enhanced CT for monitoring patients with metastatic breast cancer, according to investigators from Odense University in Denmark.

April 10, 2023

Ablaze announces progress on liver cancer therapy

By AuntMinnieEurope.com staff writers

Ablaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. The plans is to market the new drug in China, where the company is headquartered.

April 2, 2023

Getz Healthcare, Subtle Medical sign distribution deal

By AuntMinnieEurope.com staff writers

Australian medical equipment and software provider Getz Healthcare has signed on as a distributor for artificial intelligence (AI) software developer Subtle Medical.

March 29, 2023

Nuclidium wins award to study NET radiopharmaceutical

By AuntMinnieEurope.com staff writers

Radiopharmaceutical developer Nuclidium and the University Hospital Basel, Switzerland, have received an Investigator Award from the Neuroendocrine Tumors Research Foundation to support a phase I trial of its TraceNET copper-based diagnostic radiopharmaceutical for neuroendocrine tumors (NETs).

March 20, 2023

Previous Page

Page 19 of 124

Next Page